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Cutaneous melanoma (CM) accounts for 90% of deaths 
from skin cancer and models suggest continuous 
increases in melanoma incidence through 2031 (1). 
Breslow thickness is an important adverse staging and 
prognostic factor; however, the nodular (NM) histologic 
subtype was independently associated with higher mor-
tality risk among thin (≤ 1 mm) melanomas (2). Further 
distinct characteristics associated with NM compared to 
SSM even among thinner tumors include a higher mitotic 
rate (3), and the difficulty to detect thinner melanoma by 
skin self-examination (4). 
Total-body melanocytic nevus counts and dysplastic 
nevi are important established phenotypic markers of me-
lanoma risk, representing surrogate markers of underly-
ing genetic factors and environmental sun exposure. The 
recognition of nevus count associations with melanoma 
subtypes, and particularly with NM, may contribute to 
the understanding of the biology as well as the earlier 
detection of this aggressive melanoma subtype. This 
multicenter study aimed to examine the association of 
concomitant melanocytic nevi counts in patients with 
melanoma of the nodular type compared to the superficial 
spreading melanoma (SSM) histological type, and how 
this may differ by Breslow thickness.
METHODS
Pooled data were collected from 3 cross-sectional surveys among 
4 dermatology-based melanoma referral centers at Stanford Uni-
versity and University of Michigan in the US, at the University of 
Athens and collaborating centers in Greece, and at the University 
of Szeged in Hungary. Consecutive, newly-diagnosed patients aged 
≥ 18 years, with primary invasive melanoma of the NM and SSM 
subtype, were included. 
The same structured questionnaire was used, based on the study 
by Swetter et al. (5). Accepted criteria for histopathologic clas-
sification of SSM vs NM subtype were employed (6). The number 
of common melanocytic nevi ≥ 2 mm in diameter and clinically 
atypical nevi (CAN) on the whole body, was recorded by clinical 
examination by a dermatologist. The number of common nevi 
was recorded as either of 3 categories: zero or < 20, 20–50 nevi 
or > 50 nevi. A clinically atypical nevus was defined as a nevus 
≥ 5 mm in diameter, with variable pigmentation and an irregular 
or diffuse edge. Institutional review board/ethics approval and 
informed patient consent was obtained at all sites.
For the statistical analysis, for thinner melanoma, the use of a ≤ 2 
mm cut-off was used since only 4 NMs in the entire data set were 
diagnosed with thickness ≤ 1 mm, which precluded any reliable 
analysis. To investigate the association of thinner melanoma with 
every nevus variable (number of common nevi, presence of CAN, 
number of CAN), multiple logistic regression analysis was carried 
out including statistically significant variables from the univariate 
analysis. Each nevus variable was investigated in a separate logistic 
model. Stratified analyses for nevi were conducted by stratifying 
the data into patients aged < 50 and  ≥ 50 years, since nevi involute 
with age. All p-values were two-sided and the significance level 
was < 0.05. Analyses were carried out using STATA, version 13 
(StataCorp. 2013. Stata Statistical Software: Release 13. College 
Station, TX: StataCorp LP). 
RESULTS
Of 713 patients, 158 had NM and 555 had SSM. Patient 
and melanoma characteristics by NM or SSM histologi-
cal type are presented in Table SI1. NM were significantly 
thicker compared to SSM (median Breslow: 2.94 mm vs 
0.85 mm respectively, p < 0.001). Overall, there was no 
association of the NM or SSM type with common nevi 
counts (p = 0.826), the presence of clinically atypical nevi 
(p = 0.289), or the number of atypical nevi (p = 0.529). 
Among the 158 patients with NM, 50 (32%) had at least 
one CAN. Total nevi counts were not associated with 
the location of melanoma on the head/neck, trunk or 
extremities (data not shown). 
In multivariate logistic analysis adjusted for age, sex, 
thickness and country, there was no association of NM 
compared to SSM (reference) with nevi counts (odds 
ratio [OR] (confidence interval) [CI] 0.93 (0.55–1.58)) 
or with the number of atypical nevi (OR (95% CI) 0.81 
(0.46–1.45)). Similarly, there were no nevi associations 
in the multivariate analysis for thicker NM (> 2 mm) 
compared to thinner NM (≤ 2 mm), or for thicker SSM 
compared to thinner SSM (data not shown). 
Lower nevus counts were more frequent in older 
patients. Patients with NM ≥ 50 years old compared 
to younger patients more frequently had lower (< 20) 
nevus counts (p = 0.003), and less frequently had any 
CAN present (p < 0.001). Similar findings were found 
for SSM (data not shown). Age-stratified multivariate 
logistic regression analysis showed that for patients 
≥ 50 years old, the presence of fewer nevi (0–20) com-
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pared to 20–50 nevi was significantly more likely to be 
associated with thicker compared to thinner NM (OR 
(95% CI 3.37 (1.07–10.60)). On the other hand, this 
association of lower number of nevi was not present 
for thicker compared to thinner SSM in patients of the 
same age category (≥ 50 years old) (OR (95% CI 0.59 
(0.29–1.17)) (Table SII1).
DISCUSSION
In this study, we evaluated the association of the NM or 
SSM subtype with nevus counts, as well as the likelihood 
of thicker versus thinner melanoma with nevus counts by 
melanoma subtype. Total nevus counts or the number of 
CAN were not associated overall with NM compared to 
SSM (reference) after adjustment for Breslow thickness. 
Lower nevus counts were associated with thicker com-
pared to thinner NM in individuals older than 50 years 
old, whereas this association was not shown for SSM. 
A meta-analysis of 24 observational studies exami-
ned the association of nevus counts with histological 
subtype. It included 16,180 cases and reported similar 
nevi counts associated with melanoma of each histolo-
gical subtype, without heterogeneity among RRs: 1.31 
and 1.32 for NM and SSM, respectively (although NM 
was not directly compared to SSM) (7). Interestingly, 
higher nevus counts have been associated with thinner 
melanoma (8, 9), better survival rates independently 
of Breslow thickness (8) and, more recently, with me-
lanoma associated histologically with a nevus (10). A 
previous age-stratified study reported that for individuals 
younger than 60 years, the presence of more than 50 total 
nevi was associated with thinner melanoma, although 
the histological subtype was not investigated (9). The 
detection of thicker melanomas in patients with lower 
nevus counts may be a result of lower skin cancer awa-
reness because of lower nevus counts (9), or due to a 
more aggressive behavior of melanoma (8, 9). Our study 
showed that thicker melanomas were associated with 
lower nevus counts in older patients only for the NM 
and not for the SSM subtype, supporting the hypothesis 
of a distinct more aggressive biological pathway for 
NM. Nevus counts decrease with age via yet unknown 
mechanisms of involution (11), and a GWAS study for 
nevus density reported that the contribution of genetic 
factors in nevus density is stronger for older compared 
to younger individuals (12). 
Limitations of our study include the lack of central 
histopathology review and the inclusion of only 158 NM, 
of which only 49 NM were diagnosed in patients younger 
than 50 years old, so these findings should be replicated 
with greater numbers of NM patients. However, there 
was a statistically significant association detected despite 
the low number included. A strength of the study is the 
inclusion of rigorous data by 3 international melanoma 
referral centers.
In summary, our findings showed that when analysing 
nodular versus superficial spreading melanoma, total 
nevus counts were not significantly associated with the 
histological subtype, and that thicker NM was associated 
with lower nevus counts in middle-aged and older indi-
viduals. This finding may raise skin cancer awareness 
for individuals aged 50 and above with a low risk nevus 
phenotype. Furthermore, our results suggest that age-
specific factors may act in concert with nevus pathways 
to modulate aggressive melanoma features warranting 
further investigation.
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